SNDL (SNDL) Stock Price

SNDL Price

NASDAQ·CLOSED
1.80
​
Market closed

Revenue has compounded at 77.4% per year over the past 8 years to 946.40 M CAD. SNDL's net margin stands at -1.7%, up from -404.4% several years earlier. Analysts set a median price target of 4.98 CAD, implying 176.6% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

SNDL stock price

Access this data via the Eulerpool API

SNDL business model & stock analysis

Sundial Growers, Inc. engages in the production and distribution of flower, pre-rolls and vapes. The company is headquartered in Calgary, Alberta and currently employs 868 full-time employees. The company went IPO on 2019-08-01. The firm produces and markets premium cannabis for the adult-use market. In Sundial’s purpose-built indoor modular grow rooms, the Company produces consistent cannabis in individual and fully controlled room environments. The Company’s cannabis products are used as prescription medicines, and to enhance social, spiritual and recreational occasions. The firm sells Sundial Cannabis-branded dried flower cannabis products in a range of formats, such as pre-rolls, oils, capsules and sublingual.

Frequently asked questions about SNDL

Analysts currently set an average price target of 4.98 CAD for the SNDL stock (median: 4.98 CAD), implying +176.6 % versus the latest price. The consensus is based on 8 analyst ratings.

8 analysts currently rate the SNDL stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect SNDL to generate revenue of 908.31 M CAD and earnings per share of -0.09 CAD.

Converted at the current exchange rate, the SNDL share trades at 1.13 EUR (1.80 CAD).

The SNDL share (SNDL) is listed on 5 stock exchanges, including: NASDAQ (SNDL), Frankfurt (14K.F), München (14K.MU), Düsseldorf (14K.DU), Hamburg (14K.HM).

The expected revenue of SNDL is 908.31 M CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of SNDL is -22.43 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of SNDL is currently -21.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SNDL stock.

The price-to-sales ratio (P/S) of SNDL is currently 0.52. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the SNDL stock.

The Eulerpool Quality Score for SNDL is 2/10.

The ISIN of SNDL is CA83307B1013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of SNDL is A2PPQ6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of SNDL is SNDL. The ticker symbol is used to trade SNDL shares on the stock exchange.

Fair ValueTerminal
1.58 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
473.20 M CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Aug 1, 2019
ISIN
CA83307B1013
Cusip
86730L109
Sedol
BJV2RL7
Market capitalization
475.55 M CADSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-21.13
P/Ee 2027
180.20
P/Ee 2028
19.74
P/Ee 2029
9.48
P/Ee 2030
6.67
P/S
P/Se
0.52
EV/EBIT
—
P/B Ratio
0.43
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.24 %
Last updated Oct 8, 2026, 12:23 PM

SNDL Ticker

DÜSSELDORF · 14K.DUFRANKFURT · 14K.FHAMBURG · 14K.HMMUNICH · 14K.MUNASDAQ · SNDL

All fundamentals and in-depth analysis of SNDL

Our stock analysis for SNDL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SNDL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.